img

Global Gene Delivery or Gene Therapy Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Delivery or Gene Therapy Drug Market Insights, Forecast to 2034

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Market Analysis and InsightsGlobal Gene Delivery or Gene Therapy Drug Market
Global Gene Delivery or Gene Therapy Drug market is expected to reach to US$ 11590 million in 2024, with a positive growth of %, compared with US$ 9063 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gene Delivery or Gene Therapy Drug industry is evaluated to reach US$ 34850 million in 2029. The CAGR will be 20.2% during 2024 to 2029.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Covers
This report presents an overview of global Gene Delivery or Gene Therapy Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gene Delivery or Gene Therapy Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Segment by Application


Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gene Delivery or Gene Therapy Drug introduction, etc. Gene Delivery or Gene Therapy Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Gene Delivery or Gene Therapy Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery or Gene Therapy Drug Market Perspective (2018-2029)
2.2 Global Gene Delivery or Gene Therapy Drug Growth Trends by Region
2.2.1 Gene Delivery or Gene Therapy Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Delivery or Gene Therapy Drug Historic Market Size by Region (2018-2024)
2.2.3 Gene Delivery or Gene Therapy Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Delivery or Gene Therapy Drug Market Dynamics
2.3.1 Gene Delivery or Gene Therapy Drug Industry Trends
2.3.2 Gene Delivery or Gene Therapy Drug Market Drivers
2.3.3 Gene Delivery or Gene Therapy Drug Market Challenges
2.3.4 Gene Delivery or Gene Therapy Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Delivery or Gene Therapy Drug by Players
3.1.1 Global Gene Delivery or Gene Therapy Drug Revenue by Players (2018-2024)
3.1.2 Global Gene Delivery or Gene Therapy Drug Revenue Market Share by Players (2018-2024)
3.2 Global Gene Delivery or Gene Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Delivery or Gene Therapy Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene Delivery or Gene Therapy Drug Market Concentration Ratio
3.4.1 Global Gene Delivery or Gene Therapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery or Gene Therapy Drug Revenue in 2022
3.5 Global Key Players of Gene Delivery or Gene Therapy Drug Head office and Area Served
3.6 Global Key Players of Gene Delivery or Gene Therapy Drug, Product and Application
3.7 Global Key Players of Gene Delivery or Gene Therapy Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery or Gene Therapy Drug Breakdown Data by Type
4.1 Global Gene Delivery or Gene Therapy Drug Historic Market Size by Type (2018-2024)
4.2 Global Gene Delivery or Gene Therapy Drug Forecasted Market Size by Type (2024-2029)
5 Gene Delivery or Gene Therapy Drug Breakdown Data by Application
5.1 Global Gene Delivery or Gene Therapy Drug Historic Market Size by Application (2018-2024)
5.2 Global Gene Delivery or Gene Therapy Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Delivery or Gene Therapy Drug Market Size (2018-2029)
6.2 North America Gene Delivery or Gene Therapy Drug Market Size by Type
6.2.1 North America Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024)
6.2.2 North America Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029)
6.2.3 North America Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
6.3 North America Gene Delivery or Gene Therapy Drug Market Size by Application
6.3.1 North America Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024)
6.3.2 North America Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029)
6.3.3 North America Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
6.4 North America Gene Delivery or Gene Therapy Drug Market Size by Country
6.4.1 North America Gene Delivery or Gene Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024)
6.4.3 North America Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene Delivery or Gene Therapy Drug Market Size (2018-2029)
7.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Type
7.2.1 Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024)
7.2.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029)
7.2.3 Europe Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
7.3 Europe Gene Delivery or Gene Therapy Drug Market Size by Application
7.3.1 Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024)
7.3.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029)
7.3.3 Europe Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
7.4 Europe Gene Delivery or Gene Therapy Drug Market Size by Country
7.4.1 Europe Gene Delivery or Gene Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024)
7.4.3 Europe Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Delivery or Gene Therapy Drug Market Size (2018-2029)
8.2 China Gene Delivery or Gene Therapy Drug Market Size by Type
8.2.1 China Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024)
8.2.2 China Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029)
8.2.3 China Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
8.3 China Gene Delivery or Gene Therapy Drug Market Size by Application
8.3.1 China Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024)
8.3.2 China Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029)
8.3.3 China Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene Delivery or Gene Therapy Drug Market Size (2018-2029)
9.2 Asia Gene Delivery or Gene Therapy Drug Market Size by Type
9.2.1 Asia Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024)
9.2.2 Asia Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029)
9.2.3 Asia Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
9.3 Asia Gene Delivery or Gene Therapy Drug Market Size by Application
9.3.1 Asia Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024)
9.3.2 Asia Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029)
9.3.3 Asia Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
9.4 Asia Gene Delivery or Gene Therapy Drug Market Size by Region
9.4.1 Asia Gene Delivery or Gene Therapy Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Delivery or Gene Therapy Drug Market Size by Region (2018-2024)
9.4.3 Asia Gene Delivery or Gene Therapy Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery or Gene Therapy Drug Introduction
11.1.4 Biogen Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery or Gene Therapy Drug Introduction
11.2.4 Novartis Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery or Gene Therapy Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery or Gene Therapy Drug Introduction
11.6.4 Amgen Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery or Gene Therapy Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Gene Delivery or Gene Therapy Drug Introduction
11.9.4 Sunway Biotech Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.9.5 Sunway Biotech Recent Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Gene Delivery or Gene Therapy Drug Introduction
11.10.4 SIBIONO Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.10.5 SIBIONO Recent Developments
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes Gene Delivery or Gene Therapy Drug Introduction
11.11.4 AnGes Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.11.5 AnGes Recent Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Introduction
11.12.4 Orchard Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.12.5 Orchard Therapeutics Recent Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Introduction
11.13.4 Human Stem Cells Institute Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024)
11.13.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Delivery or Gene Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Delivery or Gene Therapy Drug Market Share by Region (2018-2024)
Table 8. Global Gene Delivery or Gene Therapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Delivery or Gene Therapy Drug Market Share by Region (2024-2029)
Table 10. Gene Delivery or Gene Therapy Drug Market Trends
Table 11. Gene Delivery or Gene Therapy Drug Market Drivers
Table 12. Gene Delivery or Gene Therapy Drug Market Challenges
Table 13. Gene Delivery or Gene Therapy Drug Market Restraints
Table 14. Global Gene Delivery or Gene Therapy Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Delivery or Gene Therapy Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Gene Delivery or Gene Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery or Gene Therapy Drug as of 2022)
Table 17. Global Gene Delivery or Gene Therapy Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Gene Delivery or Gene Therapy Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Gene Delivery or Gene Therapy Drug, Headquarters and Area Served
Table 20. Global Key Players of Gene Delivery or Gene Therapy Drug, Product and Application
Table 21. Global Key Players of Gene Delivery or Gene Therapy Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Delivery or Gene Therapy Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Delivery or Gene Therapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Delivery or Gene Therapy Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Delivery or Gene Therapy Drug Revenue Share by Application (2018-2024)
Table 29. Global Gene Delivery or Gene Therapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Delivery or Gene Therapy Drug Revenue Share by Application (2024-2029)
Table 31. North America Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Gene Delivery or Gene Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Gene Delivery or Gene Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Gene Delivery or Gene Therapy Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Gene Delivery or Gene Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Gene Delivery or Gene Therapy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Gene Delivery or Gene Therapy Drug Product
Table 66. Biogen Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Gene Delivery or Gene Therapy Drug Product
Table 71. Novartis Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Company Details
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Gene Delivery or Gene Therapy Drug Product
Table 76. Gilead Sciences Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 77. Gilead Sciences Recent Developments
Table 78. Sarepta Therapeutics Company Details
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Product
Table 81. Sarepta Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 82. Sarepta Therapeutics Recent Developments
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Product
Table 86. Alnylam Pharmaceuticals Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 87. Alnylam Pharmaceuticals Recent Developments
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Gene Delivery or Gene Therapy Drug Product
Table 91. Amgen Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 92. Amgen Recent Developments
Table 93. Spark Therapeutics Company Details
Table 94. Spark Therapeutics Business Overview
Table 95. Spark Therapeutics Gene Delivery or Gene Therapy Drug Product
Table 96. Spark Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 97. Spark Therapeutics Recent Developments
Table 98. Akcea Therapeutics Company Details
Table 99. Akcea Therapeutics Business Overview
Table 100. Akcea Therapeutics Gene Delivery or Gene Therapy Drug Product
Table 101. Akcea Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 102. Akcea Therapeutics Recent Developments
Table 103. Sunway Biotech Company Details
Table 104. Sunway Biotech Business Overview
Table 105. Sunway Biotech Gene Delivery or Gene Therapy Drug Product
Table 106. Sunway Biotech Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 107. Sunway Biotech Recent Developments
Table 108. SIBIONO Company Details
Table 109. SIBIONO Business Overview
Table 110. SIBIONO Gene Delivery or Gene Therapy Drug Product
Table 111. SIBIONO Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 112. SIBIONO Recent Developments
Table 113. AnGes Company Details
Table 114. AnGes Business Overview
Table 115. AnGes Gene Delivery or Gene Therapy Drug Product
Table 116. AnGes Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 117. AnGes Recent Developments
Table 118. Orchard Therapeutics Company Details
Table 119. Orchard Therapeutics Business Overview
Table 120. Orchard Therapeutics Gene Delivery or Gene Therapy Drug Product
Table 121. Orchard Therapeutics Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 122. Orchard Therapeutics Recent Developments
Table 123. Human Stem Cells Institute Company Details
Table 124. Human Stem Cells Institute Business Overview
Table 125. Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Product
Table 126. Human Stem Cells Institute Revenue in Gene Delivery or Gene Therapy Drug Business (2018-2024) & (US$ Million)
Table 127. Human Stem Cells Institute Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Delivery or Gene Therapy Drug Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Delivery or Gene Therapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Gene Delivery or Gene Therapy Drug Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Delivery or Gene Therapy Drug Report Years Considered
Figure 11. Global Gene Delivery or Gene Therapy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Delivery or Gene Therapy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Delivery or Gene Therapy Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Delivery or Gene Therapy Drug Market Share by Players in 2022
Figure 15. Global Top Gene Delivery or Gene Therapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery or Gene Therapy Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Delivery or Gene Therapy Drug Revenue in 2022
Figure 17. North America Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
Figure 19. North America Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
Figure 20. North America Gene Delivery or Gene Therapy Drug Market Share by Country (2018-2029)
Figure 21. United States Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Delivery or Gene Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
Figure 25. Europe Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
Figure 26. Europe Gene Delivery or Gene Therapy Drug Market Share by Country (2018-2029)
Figure 27. Germany Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Gene Delivery or Gene Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
Figure 35. China Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
Figure 36. Asia Gene Delivery or Gene Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
Figure 38. Asia Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
Figure 39. Asia Gene Delivery or Gene Therapy Drug Market Share by Region (2018-2029)
Figure 40. Japan Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gene Delivery or Gene Therapy Drug Market Share by Country (2018-2029)
Figure 50. Brazil Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Gene Delivery or Gene Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 61. Amgen Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 62. Spark Therapeutics Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 63. Akcea Therapeutics Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 64. Sunway Biotech Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 65. SIBIONO Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 66. AnGes Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 67. Orchard Therapeutics Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 68. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery or Gene Therapy Drug Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed